Novel Apoptotic Regulators in Carcinogenesis

Name: Novel Apoptotic Regulators in Carcinogenesis
Price: 296.98 AUD
Availability: OutOfStock
ISBN: 9789400794931

George G. Chen, Paul B.S. Lai

$370.95 $296.98

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We will update you on expected arrival time to us. If this delay is too long, please let us know within 2 business days and we can give you options regarding cancelling or adjusting your order. More details on cancelling your order can be found in our Terms of Trade.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Springer
21 September 2014

Pharmaceutical industries; Oncology; Pharmacology

Our recent understanding of the cellular and molecular defects and the regulation of the apoptotic signalling pathways has resulted in rationally designed anticancer strategies and the development of novel agents that regulates apoptosis. A comprehensive review of all apoptotic-related anticancer therapies is not the purpose of this book. However, in the volume of this book with 11 chapters, we have described a number of novel apoptotic regulators that have shown promising value and also great feasibility for cancer treatment. These novel agents either occur naturally or are chemically synthesized. While we are excited about the discovery and development of these novel apoptotic regulators as potential anticancer agents, a degree of caution should be always borne in mind when interpreting the success of preclinical pro-apoptotic candidates since potential problems inevitably lie ahead. These problems usually include target specificity, unanticipated toxicity, compound stability, formulation issues, pharmacokinetic and pharmacodynamic profiles. Nevertheless, we believe that this collection of 11 chapters by established leaders in the area of apoptosis will be of great interest to not only academics working in the field of cancer research and apoptosis but also pharmaceutical and pharmacological industries that . We are looking forward to the further development to push these potential agents toward clinical stage.

Edited by: George G. Chen, Paul B.S. Lai
Imprint: Springer
Edition: 2012 ed.
Dimensions: Height: 235mm, Width: 155mm, Spine: 17mm
Weight: 480g
ISBN: 9789400794931
ISBN 10: 9400794932
Pages: 300
Publication Date: 21 September 2014
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Preface.-1 Apoptosis Inducer from Streblus asper Extracts for Cancer Chemoprevention.- 2 Apoptosis Induction by Nimbolide, a Limonoid from Azadirachta indica: Molecular Targets and Signaling Networks.- 3 Heterocyclics as inducers of apoptosis.- 4 Anthocyanins as Apoptotic Agents.- 5 Apoptosis as a mechanism involved in the anticancer effect of dietary n-3 polyunsaturated fatty acids.- 6 Apoptotic Pathways Upon Arsenite Treatment.- 7 Flavokawains in Cancer Prevention and Treatment: Potentials and Challenges.- 8 Progesterone Receptor Modulators Induce Apoptosis in Mammary Tumors and Uterine Leiomyomas.- 9 Apoptotic regulators and its clinical implication in mammary carcinoma.- 10 Curcumin analogs as inhibitors of the Jak-STAT signal transduction pathway.- 11 Targeting cancer by betulin and betulinic acid. Abbreviations. Subject index.

Reviews for Novel Apoptotic Regulators in Carcinogenesis

From the reviews: “This book is appropriate for scientific professionals in the field of basic cancer research, drug development, and cancer medicine, as well as professionals in the pharmaceutical and pharmacological industries. … This book provides well-summarized information on interesting anticancer agents which have been substantially studied recently on their ability to induce apoptosis in cancer cells. … The book is a good source of information for the scientific community and medicinal industries who are interested in development of anticancer drugs.” (Qi Chen, Doody’s Review Service, January, 2013)